We partner with health systems to offer AmDTx to patients and employees, with the goal of improving both mental health and human performance.
Our partnerships with health systems provide physicians with a means to personalise therapy for their patients. A major benefit of AmDTx in the healthcare setting is the speed of deployment. Individuals worldwide face long wait times for mental health services (OECD Waiting Times for Health Services, 2020). AmDTx adapts to the needs of every patient and provides objective wellbeing insights obtained between healthcare visits that physicians can leverage for treatment decisions.
Scale clinical practices through digital integration within AmDTx.
Personalise treatment regimens with objective quantification of wellbeing.
Deliver the latest in digital mental healthcare to patients.
Mobio Interactive’s digital therapeutic platform “AmDTx” is CE MDD Class I and DCB0129 certified; GDPR-, HIPAA- and PHIPA-compliant; and undergoing certification for CE MDR Class IIa, ISO 13485, ISO 9000 and ISO 27001.
Validating the accuracy of our digital biomarkers and the efficacy of our digital theragnostic platform, AmDTx.
Effective and accessible healthcare for every human.